Gennex Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 335.03 million compared to INR 186.57 million a year ago. Revenue was INR 355.23 million compared to INR 207.99 million a year ago. Net income was INR 44.95 million compared to INR 20.37 million a year ago. Basic earnings per share from continuing operations was INR 0.158 compared to INR 0.117 a year ago. Diluted earnings per share from continuing operations was INR 0.144 compared to INR 0.117 a year ago. Basic earnings per share was INR 0.158 compared to INR 0.117 a year ago. Diluted earnings per share was INR 0.144 compared to INR 0.117 a year ago.
For the full year, sales was INR 867.14 million compared to INR 656.03 million a year ago. Revenue was INR 916.2 million compared to INR 695.57 million a year ago. Net income was INR 131.75 million compared to INR 49.21 million a year ago. Basic earnings per share from continuing operations was INR 0.666 compared to INR 0.351 a year ago. Diluted earnings per share from continuing operations was INR 0.608 compared to INR 0.319 a year ago. Basic earnings per share was INR 0.666 compared to INR 0.319 a year ago. Diluted earnings per share was INR 0.608 compared to INR 0.319 a year ago.